Chronic HIV Infections

Infectious Diseases
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Chipscreen Biosciences
Chipscreen BiosciencesChina - Shenzhen
2 programs
1
1
ART plus ChidamidePhase 2/31 trial
ChidamidePhase 1/21 trial
Active Trials
NCT02513901CompletedEst. Feb 2016
NCT02902185UnknownEst. Dec 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Chipscreen BiosciencesART plus Chidamide
Chipscreen BiosciencesChidamide

Clinical Trials (2)

Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir

Start: Nov 2016Est. completion: Dec 2018
Phase 2/3Unknown

Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir

Start: Aug 2015Est. completion: Feb 2016
Phase 1/2Completed

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space